Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

150
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
150
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

112
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
112

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

No Evidence of QTc Interval Prolongation With Baxdrostat Treatment: Concentration-QTc Modeling Assessment.

Pharmacology research & perspectives·2025
Same author

Population Pharmacokinetic Analysis of Balcinrenone in Healthy Participants and Participants with Heart Failure and Chronic Kidney Disease.

Clinical pharmacokinetics·2025
Same author

A Case Study of Model-Informed Drug Development of a Novel PCSK9 Antisense Oligonucleotide. Part 2: Phase 2 to Phase 3.

CPT: pharmacometrics & systems pharmacology·2025
Same author

Pharmacokinetic-pharmacodynamic (PK/PD) modelling of cotadutide effect in patients with chronic kidney disease and type 2 diabetes mellitus.

British journal of clinical pharmacology·2025
Same author

The effect of severe renal impairment on the pharmacokinetics, safety and tolerability of balcinrenone.

British journal of clinical pharmacology·2025
Same author

Concentration-QT modeling demonstrates that the selective mineralocorticoid receptor modulator, balcinrenone (AZD9977), does not prolong QT interval.

CPT: pharmacometrics & systems pharmacology·2024
Same journal

Optimizing Subcutaneous Antibody Dosing Regimens Through Operating Space Maps: rHuPH20 Case Study.

Journal of pharmacokinetics and pharmacodynamics·2026
Same journal

Mechanistic modeling of FcRn-dependent IgG drug interactions: Clinical applications and dosing implications.

Journal of pharmacokinetics and pharmacodynamics·2026
Same journal

Comparing heavy-tailed residual error models for outlier handling in population PK modeling.

Journal of pharmacokinetics and pharmacodynamics·2026
Same journal

Personalized prophylactic therapy optimization in hemophilia A using a hybrid PK-PD-TTE model and deep RL.

Journal of pharmacokinetics and pharmacodynamics·2026
Same journal

Pediatric oral cavity physiologically based pharmacokinetic model to predict pharmacokinetics of mucoadhesive atropine gel to treat sialorrhea.

Journal of pharmacokinetics and pharmacodynamics·2026
Same journal

Exposure-safety analyses of talazoparib in combination with enzalutamide in patients with metastatic castration-resistant prostate cancer (mCRPC) in the TALAPRO-2 trial.

Journal of pharmacokinetics and pharmacodynamics·2026
See all related articles

Related Experiment Video

Updated: Sep 13, 2025

Quantitative Magnetic Resonance Imaging of Skeletal Muscle Disease
09:30

Quantitative Magnetic Resonance Imaging of Skeletal Muscle Disease

Published on: December 18, 2016

19.7K

Practical guide to concentration-QTc modeling: a hands-on tutorial.

Joanna Parkinson1, Corina Dota2, Dinko Rekić3,4

  • 1Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden. Joanna.parkinson@astrazeneca.com.

Journal of Pharmacokinetics and Pharmacodynamics
|July 27, 2025
PubMed
Summary
This summary is machine-generated.

This tutorial provides practical R code for Concentration-QTc (C-QTc) analysis, a key method for assessing drug effects on the QT interval. It details data preparation, modeling, and prediction for accurate drug safety assessments.

Keywords:
C-QTc modelingExposure–response modelingPharmacokinetics/pharmacodynamicsQT assessment

More Related Videos

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0
07:41

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0

Published on: June 5, 2017

10.0K
Quantifying the Binding Interactions Between CuII and Peptide Residues in the Presence and Absence of Chromophores
11:38

Quantifying the Binding Interactions Between CuII and Peptide Residues in the Presence and Absence of Chromophores

Published on: April 5, 2022

2.6K

Related Experiment Videos

Last Updated: Sep 13, 2025

Quantitative Magnetic Resonance Imaging of Skeletal Muscle Disease
09:30

Quantitative Magnetic Resonance Imaging of Skeletal Muscle Disease

Published on: December 18, 2016

19.7K
Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0
07:41

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0

Published on: June 5, 2017

10.0K
Quantifying the Binding Interactions Between CuII and Peptide Residues in the Presence and Absence of Chromophores
11:38

Quantifying the Binding Interactions Between CuII and Peptide Residues in the Presence and Absence of Chromophores

Published on: April 5, 2022

2.6K

Area of Science:

  • Pharmacokinetics and Pharmacodynamics
  • Clinical Pharmacology
  • Biostatistics

Background:

  • Concentration-QTc (C-QTc) analysis is a standard model-based method for evaluating drug effects on QT interval duration.
  • International Council for Harmonisation (ICH) E14 guidance and a scientific white paper established C-QTc modelling methodologies.
  • Practical implementation guidance and reproducible R code are essential for scientists performing these analyses.

Purpose of the Study:

  • To provide a hands-on tutorial for the practical implementation of recommended C-QTc modelling.
  • To offer R code for the complete C-QTc analysis workflow, from data formatting to model predictions.
  • To illustrate the methodology using real-world data with active treatments and placebo.

Main Methods:

  • Utilizing R code for data preparation, exploratory data analysis, and linear mixed-effects (LME) model fitting.
  • Implementing C-QTc methodology as recommended in the scientific white paper.
  • Estimating the upper limit of the 90% confidence interval for baseline and placebo-corrected QTc (ΔΔQTc).

Main Results:

  • The tutorial demonstrates a reproducible workflow for C-QTc analysis using real QT study data.
  • The provided R code facilitates the complete analysis, including model performance assessment.
  • The workflow has been successfully applied in pharmaceutical projects and accepted by regulatory authorities.

Conclusions:

  • This tutorial offers a practical guide and reproducible R code for C-QTc analysis, supporting drug safety assessments.
  • The methodology ensures accurate estimation of drug-induced QT interval changes.
  • The workflow is validated and accepted for regulatory submissions, aiding scientists in C-QTc analysis.